Every one of those 1 sits in a single category, acquisition. Aster DM Healthcare is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 5.1 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Dr. Azad Moopen
Every one of those 1 sits in a single category, acquisition. Aster DM Healthcare is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 5.1 across the same-window beat baseline. Their average consequence score of 6 runs below the beat's 6.1 for that window. Dr. Azad Moopen appears in 1 tracked Healthcare story from March 13, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Dr. Azad Moopen. Shared-story counts are live from our verified record — not editorial picks.
Aster DM Healthcare has cleared a critical regulatory hurdle as shareholders and creditors overwhelmingly approved its merger with Quality Care India Limited (QCIL). This consolidation, backed by Blackstone, is set to create one of India's largest private healthcare networks with a significantly expanded bed capacity and geographic footprint.